Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:29 PM
Ignite Modification Date:
2025-12-24 @ 2:29 PM
NCT ID:
NCT00416559
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Histologically confirmed neuroblastoma or ganglioneuroblastoma
* Meets 1 of the following International Neuroblastoma Staging System (INSS) criteria:
* Stage 1
* Stage 2A or 2B meeting 1 of the following criteria:
* With or without N-myc amplification
* No evaluation of NMA
* Symptomatic spinal cord compression
* Stage 3\*
* Dumbbell syndrome with clinical signs of spinal cord compression\*
* NOTE: \*These patients are eligible for the study but do not undergo observation; instead they will undergo standard treatment
* Has undergone complete or gross surgical resection OR diagnostic surgical or needle biopsy
* No metastases within 1 month of diagnosis
* No skin metastases by clinical examination and MIBG scan
* Normal liver by CT scan or ultrasonography
* Normal chest X-ray (in case of nonthoracic primary site)
PATIENT CHARACTERISTICS:
* Not specified
PRIOR CONCURRENT THERAPY:
* See Disease Characteristics
* Prior steroids allowed
* No prior chemotherapy
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
20 Years
Study:
NCT00416559
Study Brief:
Protocol Section:
NCT00416559